• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性冠状动脉综合征患者需要进行非心脏手术。

Patients who require non-cardiac surgery in acute coronary syndrome.

机构信息

Columbia University Medical Center/New York Presbyterian Hospital and The Cardiovascular Research Foundation, 161 Fort Washington Ave, 6th Floor, New York, NY 10032, USA.

出版信息

Curr Cardiol Rep. 2013 Jul;15(7):373. doi: 10.1007/s11886-013-0373-3.

DOI:10.1007/s11886-013-0373-3
PMID:23686752
Abstract

The coexistence of an acute coronary syndrome (ACS) and non-cardiac surgery (NCS) in an individual patient can be summarized in two challenging clinical scenarios for the treating physician: 1) Post-operative patients who develop ACS and 2) Patients with ACS who subsequently require NCS. Both settings are characterized by a struggle on the part of treating physicians attempting to optimize antithrombotic therapies for ACS while minimizing post-surgical bleeding risk. In this review we address specific clinical issues related to patients with coexistent NCS and ACS, discussing possible management strategies balancing ischemic and bleeding risk in these complex patient scenarios.

摘要

个体患者同时存在急性冠脉综合征(ACS)和非心脏手术(NCS),这可概括为治疗医生面临的两个具有挑战性的临床情况:1)术后发生 ACS 的患者,以及 2)随后需要 NCS 的 ACS 患者。这两种情况的特点是,治疗医生在努力优化 ACS 的抗血栓治疗的同时,最大限度地降低术后出血风险。在这篇综述中,我们将讨论与同时患有 NCS 和 ACS 的患者相关的具体临床问题,讨论在这些复杂患者情况下平衡缺血和出血风险的可能管理策略。

相似文献

1
Patients who require non-cardiac surgery in acute coronary syndrome.急性冠状动脉综合征患者需要进行非心脏手术。
Curr Cardiol Rep. 2013 Jul;15(7):373. doi: 10.1007/s11886-013-0373-3.
2
Strategies to reduce bleeding among patients with ischemic heart disease treated with antiplatelet therapies.
Am J Cardiol. 2009 Sep 7;104(5 Suppl):60C-3C. doi: 10.1016/j.amjcard.2009.06.024.
3
Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.抗栓治疗在房颤和急性冠脉综合征患者中治疗药物或经皮冠状动脉介入或接受择期经皮冠状动脉介入治疗:从 AUGUSTUS 试验的见解。
Circulation. 2019 Dec 3;140(23):1921-1932. doi: 10.1161/CIRCULATIONAHA.119.043308. Epub 2019 Sep 26.
4
Relative importance of benefits and risks associated with antithrombotic therapies for acute coronary syndrome: patient and physician perspectives.急性冠状动脉综合征抗血栓治疗相关获益与风险的相对重要性:患者及医生视角
Curr Med Res Opin. 2014 Sep;30(9):1733-41. doi: 10.1185/03007995.2014.921611. Epub 2014 Jun 2.
5
Treatment strategies in non-ST-elevation acute coronary syndromes in patients undergoing percutaneous coronary intervention: an evidence-based review of clinical trial results and treatment guidelines: report on a roundtable discussion.接受经皮冠状动脉介入治疗的非ST段抬高型急性冠状动脉综合征患者的治疗策略:基于临床试验结果和治疗指南的循证综述:圆桌讨论报告
J Interv Cardiol. 2008 Aug;21(4):283-99. doi: 10.1111/j.1540-8183.2008.00375.x.
6
Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction.经皮冠状动脉介入治疗、急性冠状动脉综合征及ST段抬高型心肌梗死中出血并发症的预测因素及影响
Am J Cardiol. 2009 Sep 7;104(5 Suppl):9C-15C. doi: 10.1016/j.amjcard.2009.06.020.
7
Antiplatelet intervention in acute coronary syndrome.急性冠脉综合征的抗血小板治疗。
Am J Ther. 2009 Sep-Oct;16(5):e29-40. doi: 10.1097/MJT.0b013e31804c7238.
8
Current update on glycoprotein IIb-IIIa and direct thrombin inhibition in percutaneous coronary intervention for non-ST elevation acute coronary syndromes: balancing bleeding risk and antiplatelet efficacy.非ST段抬高型急性冠状动脉综合征经皮冠状动脉介入治疗中糖蛋白IIb-IIIa及直接凝血酶抑制的最新进展:平衡出血风险与抗血小板疗效
J Interv Cardiol. 2008 Apr;21(2):107-17. doi: 10.1111/j.1540-8183.2007.00335.x. Epub 2008 Jan 30.
9
Invasive Management Strategies and Antithrombotic Treatments in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome in China: Findings From the Improving CCC Project (Care for Cardiovascular Disease in China).中国非 ST 段抬高型急性冠状动脉综合征患者的有创管理策略和抗血栓治疗:来自改善 CCC 项目(关爱中国心血管疾病)的研究结果。
Circ Cardiovasc Interv. 2017 Jun;10(6). doi: 10.1161/CIRCINTERVENTIONS.116.004750.
10
Cardiac surgery in patients on antiplatelet and antithrombotic agents.
Semin Thorac Cardiovasc Surg. 2005 Spring;17(1):66-72. doi: 10.1053/j.semtcvs.2005.01.001.

本文引用的文献

1
Changing risk of perioperative myocardial infarction.围手术期心肌梗死风险的变化
Perm J. 2012 Fall;16(4):4-9. doi: 10.7812/TPP/12-033.
2
Stent thrombosis: insights on outcomes, predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE trials.支架血栓形成:来自 SPIRIT II、SPIRIT III、SPIRIT IV 和 COMPARE 试验的关于双抗血小板治疗中断的结局、预测因素和影响的见解。
EuroIntervention. 2012 Sep;8(5):599-606. doi: 10.4244/EIJV8I5A92.
3
Third universal definition of myocardial infarction.
心肌梗死的第三次全球定义。
J Am Coll Cardiol. 2012 Oct 16;60(16):1581-98. doi: 10.1016/j.jacc.2012.08.001. Epub 2012 Sep 5.
4
[Symptomatic acute coronary syndrome in a cohort of patients followed after noncardiac surgery].
Rev Esp Anestesiol Reanim. 2011 Nov;58(9):556-62. doi: 10.1016/s0034-9356(11)70140-2.
5
Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial.在心脏手术患者中用坎格雷洛桥接抗血小板治疗:一项随机对照试验。
JAMA. 2012 Jan 18;307(3):265-74. doi: 10.1001/jama.2011.2002.
6
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.2011年美国心脏病学会基金会/美国心脏协会/心血管造影和介入学会经皮冠状动脉介入治疗指南。美国心脏病学会基金会/美国心脏协会实践指南工作组及心血管造影和介入学会的报告。
J Am Coll Cardiol. 2011 Dec 6;58(24):e44-122. doi: 10.1016/j.jacc.2011.08.007. Epub 2011 Nov 7.
7
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2011年美国心脏病学会基金会/美国心脏协会冠状动脉旁路移植手术指南:美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2011 Dec 6;124(23):e652-735. doi: 10.1161/CIR.0b013e31823c074e. Epub 2011 Nov 7.
8
Bridging therapy after recent stent implantation: case report and review of data.近期支架植入术后的桥接治疗:病例报告及数据回顾
Cardiovasc Revasc Med. 2012 Jan-Feb;13(1):30-8. doi: 10.1016/j.carrev.2011.08.004. Epub 2011 Oct 21.
9
Dual antiplatelet therapy duration and clinical outcomes following treatment with zotarolimus-eluting stents.替格瑞洛片双联抗血小板治疗的持续时间和依维莫司洗脱支架治疗后的临床结果。
JACC Cardiovasc Interv. 2011 Oct;4(10):1119-28. doi: 10.1016/j.jcin.2011.06.017.
10
2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons.2011年美国心脏病学会基金会/美国心脏协会重点更新内容纳入《美国心脏病学会/美国心脏协会2007年不稳定型心绞痛/非ST段抬高型心肌梗死患者管理指南》:美国心脏病学会基金会/美国心脏协会实践指南工作组与美国家庭医师学会、心血管造影和介入学会以及胸外科医师学会合作制定的报告。
J Am Coll Cardiol. 2011 May 10;57(19):e215-367. doi: 10.1016/j.jacc.2011.02.011.